| Office | Acting Commissioner of Food and Drugs |
|---|---|
| Term | January 20, 2017 - May 11, 2017 |
| Term 2 | April 1, 2015 - February 22, 2016 |
| Preceded 2 | Margaret Hamburg |
| Succeeded 2 | Robert Califf |
| President 2 | Barack Obama |
| President | Donald Trump |
| Preceded | Robert Califf |
| Succeeded | Scott Gottlieb |
| Office 3 | Deputy Commissioner for Food and Veterinary Medicine |
| President 3 | Barack Obama |
| Term start 3 | April 1, 2015 |
| Term end 3 | February 21, 2016 |
| Predecessor 3 | Margaret Hamburg |
| Successor 3 | Robert Califf |
| Birth place | Philadelphia, Pennsylvania, U.S. |
| Alma mater | University of Pennsylvania |
Stephen Ostroff is an American physician. He served as acting commissioner of the U.S. Food and Drug Administration from April 1, 2015,[1] to February 21, 2016,[2] and from January to May 2017.[3]
Biography
Ostroff is a 1981 graduate of the University of Pennsylvania of Medicine. He completed residencies in internal medicine at the University of Colorado Health Sciences Center and in preventive medicine at Centers for Disease Control and Prevention (CDC). He worked at the CDC, the US Public Health Service, and at the Bureau of Epidemiology of Pennsylvania. In 2013, Ostroff joined the FDA as chief medical officer in the Center for Food Safety and Applied Nutrition and senior public health advisor to FDA's Office of Foods and Veterinary Medicine and was promoted to chief scientist in 2014.[3]
References
- ^ "FDA head Margaret Hamburg to resign in March". The Washington Post
- ^ "Califf Wins Senate Confirmation Vote on FDA Top Spot". Medscape. February 24, 2016. Retrieved 2016-02-24.
- ^ Commissioner, Office of the. "FDA Organization - Meet Stephen Ostroff, M.D., Acting Commissioner of Food and Drugs". Food and Drug Administration. Archived December 18, 2019 at the Wayback Machine.